|

PRT12396 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Prelude Therapeutics1

Indications

  • Myeloproliferative Neoplasms (MPNs)1
  • Primary Myelofibrosis (PMF)1
  • Polycythemia Vera (PV)1
  • Myelofibrosis (MF)1
  • Post-essential Thrombocythemia Myelofibrosis1

Grand Rapids, Michigan1 trial

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

START Midwest, LLC

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.